CN222033419U

CN222033419U - Therapeutic device based on multifunctional electromyography biofeedback

Info

Publication number: CN222033419U
Application number: CN202322587004.1U
Authority: CN
Inventors: 吴春
Original assignee: Shenzhen Antebeier Technology Co ltd
Current assignee: Shenzhen Antebeier Technology Co ltd
Priority date: 2023-09-22
Filing date: 2023-09-22
Publication date: 2024-11-22
Anticipated expiration: 2033-09-22

Abstract

The utility model discloses a therapeutic device based on multifunctional electromyographic biofeedback, which comprises an electromyographic biofeedback therapeutic workstation; the electromyographic biofeedback therapeutic workstation comprises an electromyographic biofeedback therapeutic instrument, three electromyographic biofeedback therapeutic electrodes, a gait motion sensing terminal, an electromyographic signal acquisition electrode, an electrical stimulation electrode, a two-in-one ultrasonic acupoint stimulation electrode, and a double-sided composite physical factor therapeutic terminal; the electromyographic biofeedback therapeutic instrument comprises a two-channel electromyographic feedback therapeutic device, a two-channel electromyographic gait electrical stimulation therapeutic device, a two-channel ultrasonic therapeutic device, a planning treatment execution drive unit, and a host computer. Therefore, by combining five physical factor therapies for the rehabilitation treatment of limb motor dysfunction after stroke, multiple factor physics are used for separate or coordinated treatment to improve the healing effect.

Description

Treatment device based on multifunctional myoelectricity biofeedback

Technical Field

The utility model relates to the technical field of medical rehabilitation instruments, in particular to a multifunctional myoelectricity biofeedback-based treatment device.

Background

Cerebral apoplexy is one of the most important diseases affecting human life health at present, and hemiplegia after cerebral apoplexy mainly refers to damage of advanced central centers of brain, incapacity of controlling limb movements normally, disturbance of original reflex activities, and main symptoms of chronic diseases are uncoordinated movements among muscle groups, abnormal muscular tension and shoulder hand syndrome characteristics, and limb autonomic nerve dysfunction, inflammation and the like exist, so that normal balance and walking functions are affected.

Recovery from post-stroke motor dysfunction is a complex process in which repeated sensory input stimuli are considered to be one of the most effective mechanisms for promoting reorganization of cortical structures and functions. At present, in the application of physical factor therapy, firstly, myoelectricity biological feedback technology (electromyographic biofeedback, EMG-BFB) is adopted, feedback stimulation is carried out according to the active contraction participation components of the residual muscles of a patient, active contraction is carried out, and meanwhile, the corresponding intensity of muscle electric stimulation is given to increase central input and remodel limb functions. And the local vibration therapy (Focal Muscle Vibraton, FMV) is adopted, so that the traditional Chinese medicine composition has certain curative effects on cerebral apoplexy sequelae such as limb dyskinesia, proprioception, spasticity, contracture, shoulder-hand syndrome, lateral neglect and the like, and particularly stimulates the stretch reflex of nerve-muscle with smaller exercise load, thereby achieving the effective exercise rehabilitation effect and greatly improving the compliance of patients. Is especially suitable for people with chronic diseases such as impaired, weak or disabled movement function.

At present, in the dyskinesia disease after the treatment cerebral apoplexy, basically, two double-sided composite physical factor treatment terminals are used for separately carrying out rehabilitation treatment on patients, the equipment size is large, a rehabilitation therapist needs to replace different double-sided composite physical factor treatment terminals according to the disease condition of the patients, particularly when carrying out local vibration therapy, the rehabilitation therapist needs to carry out one-to-one treatment on muscle groups of the patients, the treatment time is long, the compliance of the patients is difficult to meet, the equipment size is large, and the patients are difficult to sink to a family patient rehabilitation and community rehabilitation center for use. Therefore, a treatment device capable of carrying out rehabilitation therapy by combining multiple physical factors should be designed for the rehabilitation process of the post-stroke dyskinesia so as to solve the problems.

Disclosure of utility model

In view of the above, the present utility model aims at overcoming the drawbacks of the prior art, and its main purpose is to provide a therapeutic device based on multifunctional myoelectricity biofeedback, which aims at rehabilitation of limb movement dysfunction after cerebral apoplexy, and adopts multiple factors to perform individual or cooperative therapy, so as to improve the healing effect.

In order to achieve the above purpose, the present utility model adopts the following technical scheme:

A treatment device based on multifunctional myoelectricity biofeedback comprises a myoelectricity biofeedback treatment workstation;

The myoelectricity biofeedback treatment workstation comprises a myoelectricity biofeedback treatment instrument, a myoelectricity biofeedback treatment three-electrode, a gait motion sensing terminal, a myoelectricity signal acquisition electrode, an electric stimulation electrode, a two-in-one ultrasonic acupoint stimulation electrode and a double-sided composite physical factor treatment terminal;

The myoelectricity biofeedback therapeutic instrument comprises a two-channel myoelectricity feedback therapeutic device, a two-channel myoelectricity gait electric stimulation therapeutic device, a two-channel ultrasonic therapeutic device, a planning therapy execution driving unit and an upper computer;

The two-channel myoelectricity feedback treatment device is provided with a main control chip A, and the main control chip A is respectively connected with the upper computer and the myoelectricity biofeedback treatment three electrodes; the two-channel myoelectric gait electric stimulation treatment device is provided with a main control chip B, a two-channel myoelectric signal acquisition device and a two-channel electric stimulation treatment device, wherein the main control chip B is connected with the upper computer; one end of the two-channel electromyographic signal acquisition device is connected with the main control chip B, and the other end of the two-channel electromyographic signal acquisition device is connected with the electromyographic signal acquisition electrode; one end of the two-channel electric stimulation treatment device is connected with the main control chip B, and the other end of the two-channel electric stimulation treatment device is connected with the electric stimulation electrode; the gait motion sensing terminal is connected with the main control chip B; the two-channel ultrasonic treatment device is provided with a main control chip C, the main control chip C is connected with the upper computer, and the two-in-one ultrasonic acupoint stimulating electrode is connected with the main control chip C; the planning treatment execution driving unit is provided with a controller, the controller is connected with the upper computer, and the double-sided composite physical factor treatment terminal is connected with the controller.

As a preferred embodiment: the two-channel myoelectricity feedback treatment device comprises two myoelectricity biofeedback driving units, wherein each myoelectricity biofeedback driving unit comprises a myoelectricity signal acquisition unit, a functional electric stimulation driving unit, a functional electric stimulation high-voltage power supply, an RS485 interface A and a main control chip A; the main control chip A is respectively connected with the electromyographic signal acquisition unit, the functional electric stimulation driving unit, the functional electric stimulation high-voltage power supply and the RS485 interface A, and the RS485 interface A is connected with the upper computer;

One myoelectricity biofeedback driving unit is connected with one end of a connector A, and the other end of the connector A is connected with the myoelectricity biofeedback treatment three electrodes; the other myoelectricity biofeedback driving unit is connected with one end of a connector B, and the other end of the connector B is connected with the other myoelectricity biofeedback treatment three-electrode.

As a preferred embodiment: the two-channel myoelectric gait electric stimulation treatment device also comprises a TMUX8211 high-voltage analog switch, an RS485 interface B and a power supply management module; the TMUX8211 high-voltage analog switch is connected with the main control chip B; the RS485 interface B is connected between the main control chip B and the upper computer; the gait motion sensing terminals and the power supply management modules are respectively two, the two gait motion sensing terminals are respectively connected with one end of the connector C, D, the other ends C3, C4, D3 and D4 of the connector C, D are connected with the signal end of the main control chip B, and the power supply ends of the other ends C1, C2, D1 and D2 of the connector C, D are correspondingly connected with the two power supply management modules.

As a preferred embodiment: the two-channel electromyographic signal acquisition device comprises two electromyographic signal acquisition units and two electromyographic signal acquisition electrodes, wherein one electromyographic signal acquisition unit is connected with the main control chip B and is connected with one end of a connector E, and the other end of the connector E is connected with one electromyographic signal acquisition electrode; the other electromyographic signal acquisition unit is connected with the main control chip B and one end of the connector F, and the other end of the connector F is connected with the other electromyographic signal acquisition electrode.

As a preferred embodiment: the two-channel electric stimulation treatment device comprises two electric stimulation driving units and two electric stimulation high-voltage power supplies; the electric stimulation high-voltage power supply is correspondingly connected with the electric stimulation driving units, and the two electric stimulation driving units and the two electric stimulation high-voltage power supplies are respectively connected with the main control chip B.

As a preferred embodiment: the output signal of the electric stimulation driving unit is respectively connected with D1, D2, D3 and D4 at one end of the TMUX8211 high-voltage analog switch; the output signal of the other electric stimulation driving unit is connected with one end of a connector H, the other end of the connector H is connected with the electric stimulation electrode, the other ends S1 and S3 of the TMUX8211 high-voltage analog switch are respectively connected with a connector G, and the other end of the connector G is connected with the other electric stimulation electrode.

As a preferred embodiment: the two-channel ultrasonic treatment device further comprises two ultrasonic driving units and an RS485 interface C, wherein one ultrasonic driving unit is connected with I2 and I3 at one end of a connector I, and the other ultrasonic driving unit is connected with J2 and J3 at one end of a connector J; one end I1 of the connector I is connected with the other end S2 of the TMUX8211 high-voltage analog switch; one end J1 of the connector J is connected with the other end S4 of the TMUX8211 high-voltage analog switch; the main control chip C is respectively connected with two ultrasonic driving units and an RS485 interface C, and the RS485 interface C is connected with the upper computer; the two-in-one ultrasonic acupuncture point stimulation electrodes are two, one of the two-in-one ultrasonic acupuncture point stimulation electrodes is connected to the connector I, and the other two-in-one ultrasonic acupuncture point stimulation electrode is connected to the connector J.

As a preferred embodiment: the double-sided composite physical factor treatment terminal comprises a shell, a vertical local magnetic vibration composite factor treatment device and an myoelectricity biofeedback composite factor treatment device, wherein the shell comprises a middle shell and a silica gel pad, the interior of the middle shell is hollow, an upper opening and a lower opening are formed by the upper and lower parts of the middle shell in a penetrating way, and the silica gel pad is sleeved at the opening at the upper end of the middle shell; the vertical local magnetic vibration compound factor treatment device and the myoelectricity biological feedback compound factor treatment device are respectively arranged in the middle shell, the output end of the vertical local magnetic vibration compound factor treatment device is exposed out of the upper end opening of the middle shell, and the output end of the myoelectricity biological feedback compound factor treatment device is exposed out of the lower end opening of the middle shell; the planning treatment execution driving unit is respectively connected with the vertical local magnetic vibration compound factor treatment device and the myoelectricity biofeedback compound factor treatment device.

As a preferred embodiment: the vertical local magnetic vibration compound factor treatment device comprises a vertical local magnetic vibration device, a red light/near infrared unit, a negative pressure gas circuit unit and at least one ultrasonic transducer unit, wherein the vertical local magnetic vibration device is provided with a massage head, the red light/near infrared unit is provided with a red light/near infrared light source, the negative pressure gas circuit unit is provided with a negative pressure air suction port, the ultrasonic transducer unit is provided with an ultrasonic metal head, and the massage head, the red light/near infrared light source, the negative pressure air suction port and the ultrasonic metal head are all positioned at an opening at the upper end of the middle shell.

As a preferred embodiment: the myoelectricity biofeedback composite factor treatment device comprises a red light/near infrared unit and at least one ultrasonic transducer unit, wherein the red light/near infrared unit comprises a red light/near infrared light source, a PCB (printed circuit board) and a light-transmitting panel, a third sinking step for supporting the PCB is arranged on the inner side of an opening at the lower end of the middle shell, and the PCB is arranged on the third sinking step; the red light source/the near infrared light source is electrically mounted on the PCB; the inner side of the opening at the lower end of the middle shell is provided with a fourth sinking step, and the light-transmitting panel is arranged on the fourth sinking step and is positioned above the red light/near infrared light source; the ultrasonic transducer unit comprises an ultrasonic metal head and an ultrasonic ceramic plate, wherein the ultrasonic metal head is arranged on the light-transmitting panel, and the ultrasonic ceramic plate is positioned inside the ultrasonic metal head.

Compared with the prior art, the utility model has obvious advantages and beneficial effects, and particularly, the technical proposal can prove that the utility model provides a means for treating chronic diseases such as post-stroke dyskinesia, swelling and pain symptoms of patients with shoulder and hand syndromes by combining myoelectricity biofeedback therapy, two-in-one ultrasonic acupoint electric stimulation therapy, near infrared phototherapy, vertical local vibration therapy and negative pressure mechanical stimulation.

1. The myoelectricity biofeedback is used for treating upper limb dyskinesia after cerebral apoplexy, improving the paralysis side muscle contraction function of cerebral apoplexy patients, and inhibiting the muscle tension of spasmodic muscles, thereby improving the motor function of the patients.

2. The Low-intensity pulse ultrasound (Low-INTENSITY PULSED ULTRASOUND, LIPUS) combined electrical stimulation technology is utilized, three biophysical effects of ultrasonic warming, mechanical and physical chemistry are utilized to influence the substance metabolic process of cells, so that a micro cell massage effect is generated, the discharge of metabolites is accelerated, the ischemia and hypoxia states of cells are improved, the nutrition of tissues is improved, the regeneration capability of the tissues is improved, meanwhile, the combined functional electrical stimulation is combined with the nerve control losing muscle, so that the muscle contraction is caused by the action nerve stimulated by the lost functional electrical stimulation to replace or correct organs and limbs, the functional activity of the limbs is increased, the aging of the limbs after cerebral apoplexy is reduced, the tension of contracture muscles is reduced, and the muscle fibers are relaxed to relieve the spasticity effect.

3. The red light/near infrared light phototherapy is used for dilating blood vessels, increasing blood flow acceleration of subcutaneous tissues, improving local blood circulation, enhancing tissue metabolism and lymphatic return, promoting absorption and elimination of abnormal tumor in tissues, and relieving pain.

4. The local muscle vibration treatment is to apply specific vibration vertical stimulation generated by machinery to specific muscle tissues, so that the treatment can effectively relieve the problems of muscle tension, poor muscle contraction time sequence, uncoordinated participation of muscle groups and the like, stimulate the recruitment of active muscle fibers, increase neuromuscular connection, improve brain excitability, promote the reconstruction of brain functions and improve the recovery of the motor functions of cerebral apoplexy patients.

5. The massage technology of soft and relaxed from the distal end to the proximal end is carried out on the skin surface of the affected limb by the negative pressure mechanical stimulation treatment of local muscle tissue, repeatedly and rhythmically pushing the lymph fluid to flow in the lymphatic vessel, accelerating the centripetal backflow of lymph in tissue fluid, reducing pain receptors, relieving the sexual activity of the sympathetic nervous system and relieving the edema and pain of the upper limb of a patient similar to the free-hand lymphatic drainage method; on the other hand, mechanical vibration stimulation can stimulate the proprioceptors of the muscle shuttles, change the excitability of the cortical pathway, relieve spasm, activate and motor neurons at the same time, stimulate type II fibers, recruit more motor units, improve muscle coordination and contraction efficiency, further relieve pain and relieve swelling.

In order to more clearly illustrate the structural features and efficacy of the present utility model, a detailed description thereof will be given below with reference to the accompanying drawings and examples.

Drawings

FIG. 1 is a schematic block diagram of the therapeutic apparatus of the present utility model;

FIG. 2 is a schematic diagram of a two-in-one ultrasonic stimulation electrode structure according to the present utility model;

FIG. 3 is a schematic cross-sectional view of the two-in-one ultrasonic stimulation electrode of FIG. 2;

FIG. 4 is a schematic diagram of a three-dimensional structure of a dual-sided composite physical factor therapy terminal according to the present utility model;

FIG. 5 is a schematic perspective view of another view of a dual-sided composite physical factor therapy terminal according to the present utility model;

FIG. 6 is a schematic cross-sectional view at A-A of FIG. 4;

FIG. 7 is a schematic cross-sectional view at B-B of FIG. 4;

FIG. 8 is a schematic diagram of an exploded perspective view of a dual-sided composite physical factor therapy terminal according to the present utility model;

FIG. 9 is a schematic view of an exploded perspective view of a dual sided composite physical factor therapy terminal according to the present utility model;

FIG. 10 is a schematic diagram of a control method of a multifunctional myoelectric biofeedback based therapeutic device according to the present utility model;

FIG. 11 is a schematic diagram of a control method of the myoelectric biofeedback treatment device according to the present utility model;

FIG. 12 is a schematic block diagram of the connection principle between the two-sided compound physical factor therapy terminal and the planned therapy execution drive unit of the present utility model;

FIG. 13 is a schematic diagram of a control flow of a vertical local magnetic vibration compound factor treatment device according to the present utility model;

FIG. 14 is a schematic diagram of a control flow of the myoelectric biofeedback composite factor therapeutic device according to the present utility model;

Fig. 15 is a flow chart of a control method of the two-in-one ultrasonic acupoint stimulation therapy device of the present utility model.

The attached drawings are used for identifying and describing:

10. A housing; 11. a middle shell; 111. a first sinking step; 112. a support column; 113. a second sinking step; 114. an annular groove; 115. a third sinking step; 116. a fourth sinking step; 12. a silica gel pad; 13. an upper end opening; 14. an opening at the lower end; 15. a negative pressure adsorption zone; 16. a rubber ring; 17. a face mask; 18. a handle; 20. a vertical local magnetic vibration compound factor treatment device; 21. a vertical local magnetic vibration device; 211. a massage head; 212. a fixing plate; 213. a vibrating magnet; 214. a bobbin; 215. a spring; 22. red/near infrared unit; 221. red/near infrared light sources; 222. a PCB board; 223. a light-transmitting panel; 23. a negative pressure gas circuit unit; 231. negative pressure air suction port; 232. a negative pressure air pipe; 24. an ultrasonic transducer unit; 241. an ultrasonic metal head; 242. an ultrasonic ceramic sheet; 30. myoelectricity biofeedback compound factor therapeutic device; 31. red/near infrared unit; 32. an ultrasonic transducer unit;

100. Myoelectric biofeedback therapeutic equipment; 200. a work trolley; 300. externally hung display screen; 400. myoelectric biofeedback treatment three electrodes; 500. a gait motion sensing terminal; 600. myoelectric signal acquisition electrodes; 700. an electrical stimulation electrode; 800. two-in-one ultrasonic stimulation electrodes; 810. a flexible housing; 820. an ultrasonic transducer; 830. conducting resin; 900. double-sided composite physical factor treatment terminal.

Detailed Description

The utility model is as shown in fig. 1 to 15, a treatment device based on multifunctional myoelectricity biofeedback, the treatment device comprises a myoelectricity biofeedback treatment workstation, wherein:

The myoelectricity biofeedback treatment workstation comprises a myoelectricity biofeedback treatment instrument 100, a workbench trolley 200, an externally-hung display screen 300, a myoelectricity biofeedback treatment three-electrode 400, a gait motion sensing terminal 500, a myoelectricity signal acquisition electrode 600, an electric stimulation electrode 700, a two-in-one ultrasonic acupoint stimulation electrode and a double-sided composite physical factor treatment terminal 900.

The myoelectricity biofeedback therapeutic instrument 100 comprises a shell 910, a two-channel myoelectricity feedback therapeutic device, a two-channel myoelectricity gait electric stimulation therapeutic device, a two-channel ultrasonic therapeutic device, a planning therapy execution driving unit, an upper computer with a Bluetooth function, a TMUX8211 high-voltage analog switch, a connector A, B, C, D, E, F, G, H, I, J, K, L, an air channel connector, an air channel pipeline and an RS485 interface F, wherein the two-channel myoelectricity feedback therapeutic device is arranged in the shell 910.

The TMUX8211 high-voltage analog switch control signal is connected with the main control chip B, the input signal channels are respectively connected with the electric stimulation driving unit, the output signal channels are respectively connected with the connector G and the connector I, J, and the achievable stimulation signals are output to the electric stimulation electrode 700 and the two-in-one ultrasonic acupoint stimulation electrode; the voltage output signal of the power supply management unit is connected with a two-channel myoelectricity feedback treatment device, a two-channel myoelectricity gait electric stimulation treatment device, a two-channel ultrasonic treatment device, a planning treatment execution driving unit and a TMUX8211 high-voltage analog switch; the upper computer communication signal with the Bluetooth function is connected with the two-channel myoelectricity feedback treatment device, the two-channel myoelectricity detection and electric stimulation treatment device, the two-channel ultrasonic treatment device and the planning treatment execution driving unit through the RS485 interface F by a 485 bus.

The two-channel myoelectricity feedback treatment device is provided with a main control chip A, and the main control chip A is respectively connected with the upper computer and the myoelectricity biofeedback treatment three electrodes 400; the two-channel myoelectric gait electric stimulation treatment device is provided with a main control chip B, a two-channel myoelectric signal acquisition device and a two-channel electric stimulation treatment device, wherein the main control chip B is connected with the upper computer; one end of the two-channel electromyographic signal acquisition device is connected with the main control chip B, and the other end is connected with the electromyographic signal acquisition electrode 600; one end of the two-channel electric stimulation treatment device is connected with the main control chip B, and the other end is connected with the electric stimulation electrode 700; the gait motion sensing terminal 500 is connected with the main control chip B; the two-channel ultrasonic treatment device is provided with a main control chip C, the main control chip C is connected with the upper computer, and the two-in-one ultrasonic acupoint stimulating electrode is connected with the main control chip C; the planned treatment execution driving unit is provided with a controller, the controller is connected with the upper computer, and the double-sided composite physical factor treatment terminal 900 is connected with the controller.

The two-channel myoelectricity feedback treatment device comprises two myoelectricity biofeedback driving units, wherein each myoelectricity biofeedback driving unit comprises a myoelectricity signal acquisition unit, a functional electric stimulation driving unit, a functional electric stimulation high-voltage power supply, an RS485 interface A and a main control chip A; the main control chip A is respectively connected with the electromyographic signal acquisition unit, the functional electric stimulation driving unit, the functional electric stimulation high-voltage power supply and the RS485 interface A, and the RS485 interface A is connected with the upper computer.

One of the myoelectricity biofeedback driving units is connected with one end of a connector A, and the other end of the connector A is connected with the myoelectricity biofeedback treatment three electrode 400; the other myoelectricity biofeedback driving unit is connected with one end of a connector B, and the other end of the connector B is connected with the other myoelectricity biofeedback treatment three electrode 400.

The two-channel myoelectric gait electric stimulation treatment device also comprises a TMUX8211 high-voltage analog switch, an RS485 interface B and a power supply management module; the TMUX8211 high-voltage analog switch is connected with the main control chip B; the RS485 interface B is connected between the main control chip B and the upper computer; the two gait motion sensing terminals 500 and the power supply management modules are respectively arranged, the two gait motion sensing terminals 500 are respectively connected with one end of a connector C, D, the other ends C3, C4, D3 and D4 of the connector C, D are connected with the signal end of the main control chip B, and the power supply ends of the other ends C1, C2, D1 and D2 of the connector C, D are correspondingly connected with the two power supply management modules; the two gait motion sensing terminals 500 can collect lower limb movement and limb states of the lower limb movement disorder, and the main control chip B is used for analysis and evaluation.

The two-channel electromyographic signal acquisition device comprises two electromyographic signal acquisition units and two electromyographic signal acquisition electrodes 600, wherein one electromyographic signal acquisition unit is connected with the main control chip B and is connected with one end of a connector E, and the other end of the connector E is connected with one electromyographic signal acquisition electrode 600; the other electromyographic signal acquisition unit is connected with the main control chip B and one end of a connector F, and the other end of the connector F is connected with the other electromyographic signal acquisition electrode 600.

The two-channel electric stimulation treatment device comprises two electric stimulation driving units and two electric stimulation high-voltage power supplies; the electric stimulation high-voltage power supply is correspondingly connected with the electric stimulation driving units, and the two electric stimulation driving units and the two electric stimulation high-voltage power supplies are respectively connected with the main control chip B. The output signal of the electric stimulation driving unit is respectively connected with D1, D2, D3 and D4 at one end of the TMUX8211 high-voltage analog switch; the output signal of the other electric stimulation driving unit is connected with one end of a connector H, the other end of the connector H is connected with the electric stimulation electrode 700, the other ends S1 and S3 of the TMUX8211 high-voltage analog switch are respectively connected with a connector G, and the other end of the connector G is connected with the other electric stimulation electrode 700.

The two-channel ultrasonic treatment device further comprises two ultrasonic driving units and an RS485 interface C, wherein one ultrasonic driving unit is connected with I2 and I3 at one end of a connector I, and the other ultrasonic driving unit is connected with J2 and J3 at one end of a connector J; one end I1 of the connector I is connected with the other end S2 of the TMUX8211 high-voltage analog switch; one end J1 of the connector J is connected with the other end S4 of the TMUX8211 high-voltage analog switch; the main control chip C is respectively connected with two ultrasonic driving units and an RS485 interface C, and the RS485 interface C is connected with the upper computer; the two-in-one ultrasonic acupuncture point stimulation electrodes are two, one of the two-in-one ultrasonic acupuncture point stimulation electrodes is connected to the connector I, and the other two-in-one ultrasonic acupuncture point stimulation electrode is connected to the connector J.

The two-in-one ultrasonic stimulation electrode 800 comprises: a flexible housing 810, an ultrasonic transducer 820, a conductive adhesive 830; further, the ultrasonic transducer includes: the stainless steel material electric pulse electrode plate and the ultrasonic ceramic plate are fixed into a whole in an adhesive mode; further, the I1 end of the connector I is an electrical stimulation signal end, I2 and I3 are signal ends of one ultrasonic ceramic plate, the J1 end of the connector J is an electrical stimulation end, and J2 and J3 are signal ends of the other ultrasonic ceramic plate; further, the signals of the stainless steel material electrode plates are respectively connected with the signals corresponding to the connectors I, J; the two-in-one ultrasonic stimulation electrode 800 sheet comprises: the two-in-one ultrasonic acupuncture point stimulation electrode A and the two-in-one ultrasonic acupuncture point stimulation electrode B are respectively connected with the other end of the connector I, J.

The double-sided composite physical factor treatment terminal comprises a shell, a vertical local magnetic vibration composite factor treatment device 20 and a myoelectricity biofeedback composite factor treatment device 30, wherein:

The shell comprises a middle shell 11 and a silica gel pad 12, wherein the interior of the middle shell 11 is hollow, an upper opening and a lower opening are formed by the upper and lower openings, and the silica gel pad 12 is sleeved at an opening 13 at the upper end of the middle shell 11 (the silica gel pad 12 can be replaced by other elastic and flexible materials); the vertical local magnetic vibration compound factor treatment device 20 and the myoelectricity biological feedback compound factor treatment device 30 are respectively arranged in the middle shell 11, the output end of the vertical local magnetic vibration compound factor treatment device 20 is exposed out of the upper end opening 13 of the middle shell 11, and the output end of the myoelectricity biological feedback compound factor treatment device 30 is exposed out of the lower end opening 14 of the middle shell 11; the planning treatment execution driving unit is respectively connected with the vertical local magnetic vibration compound factor treatment device 20 and the myoelectricity biological feedback compound factor treatment device 30. In addition, handles 18 for conveniently lifting and placing the double-sided composite physical factor treatment terminal are respectively arranged on the two side walls of the middle shell 11.

The vertical local magnetic vibration compound factor treatment device 20 comprises a vertical local magnetic vibration device 21, a red light/near infrared unit 22, a negative pressure air path unit 23 and at least one ultrasonic transducer unit 24, wherein the vertical local magnetic vibration device 21 is provided with a massage head 211, the red light/near infrared unit 22 is provided with a red light/near infrared light source 221, the negative pressure air path unit 23 is provided with a negative pressure air suction port 231, the ultrasonic transducer unit 24 is provided with an ultrasonic metal head 241, and the massage head 211, the red light/near infrared light source 221, the negative pressure air suction port 231 and the ultrasonic metal head 241 are all positioned at the upper end opening 13 of the middle shell 11.

The vertical local magnetic vibration device 21 further comprises a fixed plate 212, a vibration magnet 213, a winding frame 214 and a spring 215, wherein a first sinking step 111 is arranged at the opening 13 at the upper end of the middle shell 11, the fixed plate 212 is arranged on the first sinking step 111, the winding frame 214 is fixedly connected to the lower surface of the fixed plate 212, and the winding frame 214 is hollow; the vibrating magnet 213 is vertically movably installed inside the bobbin 214; the spring 215 is installed inside the bobbin 214 and is positioned between the bottom wall of the bobbin 214 and the vibrating magnet 213; the massage head 211 is mounted on the upper end of the vibrating magnet 213 and is exposed out of the upper end opening 13 of the middle housing 11.

The coil is loaded with pulse excitation signals to generate an alternating pulse magnetic field, and the alternating pulse magnetic field interacts with a constant magnetic field with a sliding magnet column arranged in the coil, so that the suspended magnet column generates vertical mechanical vibration due to the continuous change of the direction of the magnetic field, the vibration energy acts on deep muscle tissues of a human body through the massage head 211 to generate the biological effect of local low-frequency vibration on the muscle group tissues, the proprioceptive input is increased, the excitability of damaged nerves is improved, the nerve regeneration is promoted, the proprioception is further improved, the excitability of cerebral cortex is increased, the capability of central nerves on motion control is improved, and the quality of the action completed by a cerebral apoplexy patient is improved; meanwhile, under the action of a magnetic field with certain intensity, the muscle group tissue accelerates the blood flow speed of blood vessels, improves the metabolism and enhancement of cells, corrects the ischemia and hypoxia state of the tissue, enhances the transport of painful substances, moves substances in tissue cells, rubs the temperature rise on tissue interfaces, enhances the dispersion process of biological membranes, increases the permeability of ions and promotes the absorption and dissipation of exudation, thereby playing the roles of easing pain, diminishing inflammation and detumescence; on the other hand, the coil generates heat temperature due to eddy current, and the warm field is transmitted to muscle tissue by adopting the massage head 211 with high heat conductivity coefficient to cause local skin temperature to rise, so as to stimulate the skin thermal receptors, relax vascular smooth muscle by thalamus reflex, dilate blood vessel and accelerate blood circulation. Due to the heat effect, the release of vascular active substances, the reduction of vascular tension, the expansion of superficial arterioles, superficial capillaries and superficial veins, the acceleration of blood circulation and the improvement of blood circulation are caused, thereby improving the cell nutrition environment, strengthening the metabolism of cells, fundamentally eliminating pain recovery, and having certain curative effects on limb dyskinesia, proprioception, spasticity, contracture, shoulder-hand syndrome, lateral neglect and the like.

The red light/near infrared unit 22 further comprises a PCB 222 and a light-transmitting panel 223, four corners of the inner side of the upper opening 13 of the middle housing 11 are respectively provided with a support column 112 for supporting the PCB 222, and the PCB 222 is mounted on the support column 112; the red/near infrared light source 221 is electrically mounted on the PCB 222; the second sinking step 113 is disposed inside the upper opening 13 of the middle housing 11, and the light-transmitting panel 223 is mounted on the second sinking step 113 and above the red/near infrared light source 221. The negative pressure air path unit 23 further comprises a negative pressure air pipe 232, and the negative pressure air pipe 232 is positioned in the middle shell 11 and is communicated with the negative pressure air suction port 231; the negative pressure suction port 231 is located on the light-transmitting panel 223. The ultrasonic transducer unit 24 further includes an ultrasonic ceramic plate 242, the ultrasonic metal head 241 is mounted on the light-transmitting panel 223, and the ultrasonic ceramic plate 242 is located inside the ultrasonic metal head 241. The upper end of the middle shell 11 is circumferentially provided with an annular groove 114 for embedding the silica gel pad 12, the lower end of the silica gel pad 12 is embedded in the annular groove 114, the upper end of the silica gel pad 12 exceeds the upper end of the middle shell 11, the silica gel pad 12 is formed into a negative pressure adsorption zone 15 by encircling an opening 13 at the upper end of the middle shell 11, and the negative pressure air suction port 231 is positioned at the bottom of the negative pressure adsorption zone 15.

The characteristics of spectral wavelengths (including laser, light emitting diode and broadband light) of non-ionized forms from light sources in visible and near infrared spectrums are used for inducing physiological changes and therapeutic effects, meanwhile, specific spectral irradiation is utilized for having anti-inflammatory, tissue repair and other biological functions, the expression level of inflammatory factors and chemokines in PBMC can be effectively reduced, analgesic functions can be exerted through the regulation effect of the inflammatory factors and the chemokines on neuropathic pain sensitivity, clinical application finds that for chronic pain types, wherein non-specific pain refers to pain with neither exact tissue structure nor pathological changes nor clear etiology can be found, the main reasons possibly include muscle strain, myofascitis and other diseases, and red light/near infrared phototherapy can inhibit the expression of the inflammatory factors and the chemokines in PBMC, so that pain is relieved. It has good effect on anti-inflammatory and analgesic effects of local tissues as a new pain auxiliary treatment means.

The percutaneous electrical stimulation is used for restoring sensibility, blocking or weakening pain conduction through continuous electrical stimulation on focal nerves, ultrasonic therapy adopts ultrasonic waves to perform physical therapy interference on corresponding focuses, and can relieve symptoms such as focal congestion, adhesion, edema, microcirculation disturbance and the like, so that pain relief and function improvement are realized. The combination of the two physical factors acts on the focus part, is beneficial to relieving the hemiplegia and shoulder pain of cerebral apoplexy, and can strengthen the improvement effect of the upper limb functions and the joint mobility and the analgesic effect.

The myoelectricity biofeedback composite factor treatment device 30 includes a red light/near infrared unit 22 and at least one ultrasonic transducer unit 24, the red light/near infrared unit 22 includes a red light/near infrared light source 221, a PCB board 222 and a light-transmitting panel 223, a third sinking step 115 for supporting the PCB board 222 is disposed inside the lower opening 14 of the middle housing 11, and the PCB board 222 is mounted on the third sinking step 115; the red/near infrared light source 221 is electrically mounted on the PCB 222; a fourth sinking step 116 is arranged inside the lower opening 14 of the middle housing 11, and the light-transmitting panel 223 is mounted on the fourth sinking step 116 and is positioned above the red/near infrared light source 221; the ultrasonic transducer unit 24 includes an ultrasonic metal head 241 and an ultrasonic ceramic plate 242, the ultrasonic metal head 241 is mounted on the light-transmitting panel 223, and the ultrasonic ceramic plate 242 is located inside the ultrasonic metal head 241. The ultrasonic metal head 241 in the myoelectricity biofeedback composite factor treatment device 30 can be used as an electric stimulation electrode or a myoelectricity signal acquisition electrode; alternatively, an electrode may be provided on the ultrasonic metal head 241 alone. As an electromyographic signal acquisition electrode, human electromyographic signals can be acquired in real time and fed back to the controller to make proper treatment parameter adjustment, so that the treatment effect is improved.

The biofeedback Functional Electric Stimulation (FES) technology is applied, feedback stimulation is carried out according to the active contraction participation components of the residual muscles of the patient, active contraction is carried out, and meanwhile, the muscle electric stimulation with corresponding strength is given to increase central input and remodel limb functions.

The red light/near infrared light source 221 adopts LED chips with different wavelengths, the wavelength ranges from 600nm to 1000nm, the light power is between 40mW and 100mW, and the LED chips and the PCB 222 form a light/near infrared matrix light source.

And rubber rings 16 are respectively arranged on the transparent panel corresponding to the ultrasonic metal head 241 and the massage head 211 so as to prevent the ultrasonic metal head 241, the massage head 211 and the transparent panel from being damaged due to contact friction. In addition, the mask 17 is detachably mounted at the lower opening 14 of the middle housing 11, and when the myoelectricity biofeedback composite factor therapeutic device 30 is not used, the mask 17 can be sleeved on the lower opening 14 of the middle housing 11 to play a role in protection. In order to detect the working temperatures of the vertical local magnetic vibration device 21 and the ultrasonic transducer unit 24 in real time, temperature sensors are respectively arranged on the coil wound by the coil frame 214 and the ultrasonic metal head 241 to detect the temperature changes of the coil wound by the coil frame in real time, and the temperature sensors arranged on the ultrasonic metal head 241 can be attached to the grooves at the top of the ultrasonic metal head 241 (the grooves can be arranged at the top of the ultrasonic metal head 241 for accommodating the temperature sensors). The number of the massage heads 211 and the ultrasonic metal heads 241 may be plural, and the specific number may be set as needed.

The double-sided composite physical factor treatment terminal can be used as a separate device or combined with a planning treatment driving unit or embedded into other double-sided composite physical factor treatment terminals.

The planning treatment execution driving unit comprises a controller, a single or multiple vertical local magnetic vibration driving device (single or multiple vertical local vibration driving devices), a single or multiple local magnetic stimulation driving device, a single or multiple ultrasonic driving power supply device, a functional low-frequency electric stimulation driving device, a myoelectric biological signal acquisition device, a middle-frequency and low-frequency nerve stimulation driving device, a red light/near infrared light source constant-current driving device, a multiple temperature signal detection device, a negative pressure driving device and multiple analog switches; the vertical local magnetic vibration driving device, the single or multi-path ultrasonic driving device, the functional low-frequency electric stimulation driving device, the myoelectricity biological signal acquisition device, the middle and low-frequency nerve stimulation driving device, the red light/near infrared light source constant current driving device, the multi-path temperature signal detection device and the negative pressure driving device are respectively connected between the controller and the multi-path analog switch connector; the device for treating the vertical local magnetic vibration compound factor is provided with a connector B, the device for treating the myoelectricity biofeedback compound factor is provided with a connector A, the planning treatment execution driving unit is further provided with a connector B and a connector A, the connector B of the device for treating the vertical local magnetic vibration compound factor is connected with the connector B of the planning treatment execution driving unit, and the connector A of the device for treating the myoelectricity biofeedback compound factor is connected with the connector A of the planning treatment execution driving unit.

The vertical local magnetic vibration driving apparatus includes: the controller receives planning treatment execution instructions and respectively controls the magnetic stimulation driving unit and the vertical local vibration driving unit to work cooperatively or independently so as to realize electromagnetic stimulation therapy, vertical vibration therapy or vertical local muscle magnetic vibration therapy on the muscle group.

A control method applied to the multifunctional myoelectric biofeedback-based treatment device described above, comprising the steps of:

S1, a human body limb muscle treatment target graph displayed through an upper computer display screen is used for processing the human body muscle treatment target graph to generate a plurality of treatment sub-target graphs;

s2, the treatment sub-target graph is a graph of different parts of the limb, and corresponding different physical therapies are displayed according to the treatment target graph of different limbs;

S3, processing treatment target graphs of different limbs, displaying control parameters of corresponding treatment prescriptions, generating the control parameters of the treatment target prescriptions of the treatment terminal and sending the control parameters to the treatment terminal for independently executing treatment after a rehabilitation therapist adjusts parameters of symptoms of the treatment target; the user can accurately select the control area of the equipment operation page, and the use experience of the user is improved.

The utility model discloses a control method based on a multifunctional myoelectricity biofeedback treatment device, and aims to solve the problems that the multifunctional myoelectricity biofeedback treatment device adopts different physical therapies for different diseases after cerebral apoplexy in the use process, and a treatment target is generated by taking a treatment part as a target graph. Different physical therapies are realized by treating different parts of the limb, and different control parameters are adopted to effectively treat the limb, so that the corresponding relation between the treatment target part and different symptoms and relevant physical therapies is used for outputting different prescription control parameters, the treatment process is more visual, and the usability and safety of the treatment device are improved.

The design key points of the utility model are as follows: the method provides a means for treating chronic diseases such as post-stroke dyskinesia, swelling and pain symptoms of patients with shoulder hand syndrome by combining myoelectric biofeedback therapy, two-in-one ultrasonic acupoint electric stimulation therapy, near infrared phototherapy, vertical local vibration therapy and negative pressure mechanical stimulation.

According to the technical scheme, five physical factors are integrated into a treatment workstation, different symptoms after cerebral apoplexy can be realized, different physical therapies are adopted, and a single or cooperative physical therapy mode is carried out by a control method based on multifunctional myoelectricity biofeedback treatment; the treatment of the diseases with diversity after cerebral apoplexy is realized through different treatment terminals and different stimulation electrodes. In addition, the independent control mode of the built-in main control chip of each treatment device is adopted, so that the operation safety of each treatment terminal is improved. After the upper computer with the Bluetooth function configures each control parameter of each treatment device, the control parameters are sent to each treatment terminal in a 485 bus mode, so that independent working treatment of each treatment device is realized, and meanwhile, the upper computer with the Bluetooth function can monitor the working condition of each treatment device, and the operation safety of each treatment device is improved.

The foregoing description is only a preferred embodiment of the present utility model, and is not intended to limit the technical scope of the present utility model, so any minor modifications, equivalent changes and modifications made to the above embodiments according to the technical principles of the present utility model still fall within the scope of the technical solutions of the present utility model.

Claims

1. A treatment device based on multi-functional myoelectricity biofeedback, its characterized in that: comprises a myoelectricity biofeedback treatment workstation;

2. The multi-functional myoelectric biofeedback-based therapeutic device according to claim 1, wherein: the two-channel myoelectricity feedback treatment device comprises two myoelectricity biofeedback driving units, wherein each myoelectricity biofeedback driving unit comprises a myoelectricity signal acquisition unit, a functional electric stimulation driving unit, a functional electric stimulation high-voltage power supply, an RS485 interface A and a main control chip A; the main control chip A is respectively connected with the electromyographic signal acquisition unit, the functional electric stimulation driving unit, the functional electric stimulation high-voltage power supply and the RS485 interface A, and the RS485 interface A is connected with the upper computer;

3. The multi-functional myoelectric biofeedback-based therapeutic device according to claim 1, wherein: the two-channel myoelectric gait electric stimulation treatment device also comprises a TMUX8211 high-voltage analog switch, an RS485 interface B and a power supply management module; the TMUX8211 high-voltage analog switch is connected with the main control chip B; the RS485 interface B is connected between the main control chip B and the upper computer; the gait motion sensing terminals and the power supply management modules are respectively two, the two gait motion sensing terminals are respectively connected with one end of the connector C, D, the other ends C3, C4, D3 and D4 of the connector C, D are connected with the signal end of the main control chip B, and the power supply ends of the other ends C1, C2, D1 and D2 of the connector C, D are correspondingly connected with the two power supply management modules.

4. A multi-functional myoelectric biofeedback-based therapeutic device according to claim 3, wherein: the two-channel electromyographic signal acquisition device comprises two electromyographic signal acquisition units and two electromyographic signal acquisition electrodes, wherein one electromyographic signal acquisition unit is connected with the main control chip B and is connected with one end of a connector E, and the other end of the connector E is connected with one electromyographic signal acquisition electrode; the other electromyographic signal acquisition unit is connected with the main control chip B and one end of the connector F, and the other end of the connector F is connected with the other electromyographic signal acquisition electrode.

5. A multi-functional myoelectric biofeedback-based therapeutic device according to claim 3, wherein: the two-channel electric stimulation treatment device comprises two electric stimulation driving units and two electric stimulation high-voltage power supplies; the electric stimulation high-voltage power supply is correspondingly connected with the electric stimulation driving units, and the two electric stimulation driving units and the two electric stimulation high-voltage power supplies are respectively connected with the main control chip B.

6. The multi-functional myoelectric biofeedback-based therapeutic device according to claim 5, wherein: the output signal of the electric stimulation driving unit is respectively connected with D1, D2, D3 and D4 at one end of the TMUX8211 high-voltage analog switch; the output signal of the other electric stimulation driving unit is connected with one end of a connector H, the other end of the connector H is connected with the electric stimulation electrode, the other ends S1 and S3 of the TMUX8211 high-voltage analog switch are respectively connected with a connector G, and the other end of the connector G is connected with the other electric stimulation electrode.

7. A multi-functional myoelectric biofeedback-based therapeutic device according to claim 3, wherein: the two-channel ultrasonic treatment device further comprises two ultrasonic driving units and an RS485 interface C, wherein one ultrasonic driving unit is connected with I2 and I3 at one end of a connector I, and the other ultrasonic driving unit is connected with J2 and J3 at one end of a connector J; one end I1 of the connector I is connected with the other end S2 of the TMUX8211 high-voltage analog switch; one end J1 of the connector J is connected with the other end S4 of the TMUX8211 high-voltage analog switch; the main control chip C is respectively connected with two ultrasonic driving units and an RS485 interface C, and the RS485 interface C is connected with the upper computer; the two-in-one ultrasonic acupuncture point stimulation electrodes are two, one of the two-in-one ultrasonic acupuncture point stimulation electrodes is connected to the connector I, and the other two-in-one ultrasonic acupuncture point stimulation electrode is connected to the connector J.

8. The multi-functional myoelectric biofeedback-based therapeutic device according to claim 1, wherein: the double-sided composite physical factor treatment terminal comprises a shell, a vertical local magnetic vibration composite factor treatment device and an myoelectricity biofeedback composite factor treatment device, wherein the shell comprises a middle shell and a silica gel pad, the interior of the middle shell is hollow, an upper opening and a lower opening are formed by the upper and lower parts of the middle shell in a penetrating way, and the silica gel pad is sleeved at the opening at the upper end of the middle shell; the vertical local magnetic vibration compound factor treatment device and the myoelectricity biological feedback compound factor treatment device are respectively arranged in the middle shell, the output end of the vertical local magnetic vibration compound factor treatment device is exposed out of the upper end opening of the middle shell, and the output end of the myoelectricity biological feedback compound factor treatment device is exposed out of the lower end opening of the middle shell; the planning treatment execution driving unit is respectively connected with the vertical local magnetic vibration compound factor treatment device and the myoelectricity biofeedback compound factor treatment device.

9. The multi-functional myoelectric biofeedback-based therapeutic device according to claim 8, wherein: the vertical local magnetic vibration compound factor treatment device comprises a vertical local magnetic vibration device, a red light/near infrared unit, a negative pressure gas circuit unit and at least one ultrasonic transducer unit, wherein the vertical local magnetic vibration device is provided with a massage head, the red light/near infrared unit is provided with a red light/near infrared light source, the negative pressure gas circuit unit is provided with a negative pressure air suction port, the ultrasonic transducer unit is provided with an ultrasonic metal head, and the massage head, the red light/near infrared light source, the negative pressure air suction port and the ultrasonic metal head are all positioned at an opening at the upper end of the middle shell.

10. The multi-functional myoelectric biofeedback-based therapeutic device according to claim 8, wherein: the myoelectricity biofeedback composite factor treatment device comprises a red light/near infrared unit and at least one ultrasonic transducer unit, wherein the red light/near infrared unit comprises a red light/near infrared light source, a PCB (printed circuit board) and a light-transmitting panel, a third sinking step for supporting the PCB is arranged on the inner side of an opening at the lower end of the middle shell, and the PCB is arranged on the third sinking step; the red light source/the near infrared light source is electrically mounted on the PCB; the inner side of the opening at the lower end of the middle shell is provided with a fourth sinking step, and the light-transmitting panel is arranged on the fourth sinking step and is positioned above the red light/near infrared light source; the ultrasonic transducer unit comprises an ultrasonic metal head and an ultrasonic ceramic plate, wherein the ultrasonic metal head is arranged on the light-transmitting panel, and the ultrasonic ceramic plate is positioned inside the ultrasonic metal head.